LAUSR

Introduction: Mantle cell lymphoma (MCL) is an aggressive, rare, form of non-Hodgkin lymphoma. Due to the rarity of MCL, it is important that hematologists/oncologists (hem/oncs) and nurses are competent utilizing treatments in order to optimize patient outcomes. The goal of this initiative was to determine if online education could improve hem/onc and nurse clinical knowledge and competence using BTK inhibitors (BTKi) to treat MCL. Methods: The format was an online continuing medical education (CME)-certified text-based activity composed of 2 patient cases with interactive questions. Evidence-based educational feedback was provided following each response. Three multiple-choice competence questions and 1 self-efficacy question were selected from the set of intra-activity questions to be repeated immediately after activity participation. Questions assessed the impact of the education with a repeated pairs pre-assessment/post-assessment study design where each participant served as his/her own control. A chi-square test was used to identify differences between preand post-assessment responses. P values were calculated; those < 0.05 were considered statistically significant. The activity launched online September 20, 2018 and data were collected through March 15, 2019. Results: Results are for those who have completed the preand postassessment questions during the study period (n = 166 hem/onc; n = 363 nurses). Upon completion of the activity, an improvement from preto post-assessmentwas observed in the hem/oncs and nurse’s ability to: